Structural Racism in Precision Medicine: Leaving No One Behind

Overview

Journal BMC Med Ethics

Publisher Biomed Central

Specialty Medical Ethics

Date 2020 Feb 21

PMID 32075640

Citations 39

Authors

Lester Darryl Genevieve

Andrea Martani

David Shaw

Bernice Simone Elger

Tenzin Wangmo

Affiliations

Soon will be listed here.

Abstract

Background: Precision medicine (PM) is an emerging approach to individualized care. It aims to help physicians better comprehend and predict the needs of their patients while effectively adopting in a timely manner the most suitable treatment by promoting the sharing of health data and the implementation of learning healthcare systems. Alongside its promises, PM also entails the risk of exacerbating healthcare inequalities, in particular between ethnoracial groups. One often-neglected underlying reason why this might happen is the impact of structural racism on PM initiatives. Raising awareness as to how structural racism can influence PM initiatives is paramount to avoid that PM ends up reproducing the pre-existing health inequalities between different ethnoracial groups and contributing to the loss of trust in healthcare by minority groups.

Main Body: We analyse three nodes of a process flow where structural racism can affect PM's implementation. These are: (i) the collection of biased health data during the initial encounter of minority groups with the healthcare system and researchers, (ii) the integration of biased health data for minority groups in PM initiatives and (iii) the influence of structural racism on the deliverables of PM initiatives for minority groups. We underscore that underappreciation of structural racism by stakeholders involved in the PM ecosystem can be at odds with the ambition of ensuring social and racial justice. Potential specific actions related to the analysed nodes are then formulated to help ensure that PM truly adheres to the goal of leaving no one behind, as endorsed by member states of the United Nations for the 2030 Agenda for Sustainable Development.

Conclusion: Structural racism has been entrenched in our societies for centuries and it would be naïve to believe that its impacts will not spill over in the era of PM. PM initiatives need to pay special attention to the discriminatory and harmful impacts that structural racism could have on minority groups involved in their respective projects. It is only by acknowledging and discussing the existence of implicit racial biases and trust issues in healthcare and research domains that proper interventions to remedy them can be implemented.

Citing Articles

Misguided Artificial Intelligence: How Racial Bias is Built Into Clinical Models.

Jindal A Brown J Hosp Med. 2025; 2(1):38021.

PMID: 40046549 PMC: 11878858. DOI: 10.56305/001c.38021.

Trusted partners, community priorities, and data protections: requirements for precision medicine research with Alaska Native peoples.

Woodbury R, Beans J, Hiratsuka V J Community Genet. 2025; .

PMID: 40029587 DOI: 10.1007/s12687-025-00779-2.

Identifying High-Priority Ethical Challenges for Precision Emergency Medicine: Nominal Group Study.

Rose C, Shearer E, Woller I, Foster A, Ashenburg N, Kim I JMIR Form Res. 2025; 9:e68371.

PMID: 39916376 PMC: 11825900. DOI: 10.2196/68371.

Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues.

Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T Hum Genomics. 2025; 19(1):8.

PMID: 39891174 PMC: 11786457. DOI: 10.1186/s40246-025-00718-9.

From one size fits all to a tailored approach: integrating precision medicine into medical education.

Sbitan L, Alzraikat N, Tanous H, Saad A, Odeh M BMC Med Educ. 2025; 25(1):90.

PMID: 39827113 PMC: 11748586. DOI: 10.1186/s12909-024-06138-y.

References

Hood L, Flores M . A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol. 2012; 29(6):613-24. DOI: 10.1016/j.nbt.2012.03.004. View

Nordling L . A fairer way forward for AI in health care. Nature. 2019; 573(7775):S103-S105. DOI: 10.1038/d41586-019-02872-2. View

Courtland R . Bias detectives: the researchers striving to make algorithms fair. Nature. 2018; 558(7710):357-360. DOI: 10.1038/d41586-018-05469-3. View

Penner L, Dovidio J, West T, Gaertner S, Albrecht T, Dailey R . Aversive Racism and Medical Interactions with Black Patients: A Field Study. J Exp Soc Psychol. 2010; 46(2):436-440. PMC: 2835170. DOI: 10.1016/j.jesp.2009.11.004. View

Puumala S, Burgess K, Kharbanda A, Zook H, Castille D, Pickner W . The Role of Bias by Emergency Department Providers in Care for American Indian Children. Med Care. 2016; 54(6):562-9. PMC: 4865441. DOI: 10.1097/MLR.0000000000000533. View

Paradies Y . A systematic review of empirical research on self-reported racism and health. Int J Epidemiol. 2006; 35(4):888-901. DOI: 10.1093/ije/dyl056. View

Liu J, Hong Y, DAgostino Sr R, Wu Z, Wang W, Sun J . Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004; 291(21):2591-9. DOI: 10.1001/jama.291.21.2591. View

Sabin J, Riskind R, Nosek B . Health Care Providers' Implicit and Explicit Attitudes Toward Lesbian Women and Gay Men. Am J Public Health. 2015; 105(9):1831-41. PMC: 4539817. DOI: 10.2105/AJPH.2015.302631. View

Williams D, Mohammed S . Discrimination and racial disparities in health: evidence and needed research. J Behav Med. 2008; 32(1):20-47. PMC: 2821669. DOI: 10.1007/s10865-008-9185-0. View

10.

Mensah G, Jaquish C, Srinivas P, Papanicolaou G, Wei G, Redmond N . Emerging Concepts in Precision Medicine and Cardiovascular Diseases in Racial and Ethnic Minority Populations. Circ Res. 2019; 125(1):7-13. PMC: 6590684. DOI: 10.1161/CIRCRESAHA.119.314970. View

11.

DAgostino Sr R, Grundy S, Sullivan L, Wilson P . Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286(2):180-7. DOI: 10.1001/jama.286.2.180. View

12.

Bayer R, Galea S . Public Health in the Precision-Medicine Era. N Engl J Med. 2015; 373(6):499-501. DOI: 10.1056/NEJMp1506241. View

13.

Blumenthal G, Mansfield E, Pazdur R . Next-Generation Sequencing in Oncology in the Era of Precision Medicine. JAMA Oncol. 2015; 2(1):13-4. DOI: 10.1001/jamaoncol.2015.4503. View

14.

Keyes K, Westreich D . UK Biobank, big data, and the consequences of non-representativeness. Lancet. 2019; 393(10178):1297. PMC: 7825643. DOI: 10.1016/S0140-6736(18)33067-8. View

15.

Lee S, Cho M, Kraft S, Varsava N, Gillespie K, Ormond K . "I don't want to be Henrietta Lacks": diverse patient perspectives on donating biospecimens for precision medicine research. Genet Med. 2018; 21(1):107-113. PMC: 6289900. DOI: 10.1038/s41436-018-0032-6. View

16.

Kraft S, Cho M, Gillespie K, Halley M, Varsava N, Ormond K . Beyond Consent: Building Trusting Relationships With Diverse Populations in Precision Medicine Research. Am J Bioeth. 2018; 18(4):3-20. PMC: 6173191. DOI: 10.1080/15265161.2018.1431322. View

17.

Ramaswami R, Bayer R, Galea S . Precision Medicine from a Public Health Perspective. Annu Rev Public Health. 2017; 39:153-168. DOI: 10.1146/annurev-publhealth-040617-014158. View

18.

Viruell-Fuentes E, Miranda P, Abdulrahim S . More than culture: structural racism, intersectionality theory, and immigrant health. Soc Sci Med. 2012; 75(12):2099-106. DOI: 10.1016/j.socscimed.2011.12.037. View

19.

Rubin R . A Precision Medicine Approach to Clinical Trials. JAMA. 2016; 316(19):1953-1955. DOI: 10.1001/jama.2016.12137. View

20.

Collins F, Varmus H . A new initiative on precision medicine. N Engl J Med. 2015; 372(9):793-5. PMC: 5101938. DOI: 10.1056/NEJMp1500523. View